- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: Maryland Suspends Cookies' Baltimore License
One of the biggest and most recognized cannabis brands may end up missing out on the latest state to open the doors to adult-use laws.
One of the most popular cannabis brands in North America finds itself in a difficult position — Maryland regulators have suspended the company's license just as adult-use sales are set to roll out in the state.
Meanwhile, a cannabis operator in Canada received shareholder approval to move ahead with a notable acquisition plan.
Keep reading to find out more cannabis highlights from the past five days.
Cookies in trouble after multiple violations
Cookies has drawn the ire of state regulators in Maryland. The cannabis brand company has had its business license suspended less than a week after it opened a dispensary in Baltimore, as per a report from MJBizDaily.
The suspension was handed down by the Maryland Cannabis Administration. The decision reportedly relates to multiple violations from the store, as well as a general lack of communication as to the needs of the cannabis authority.
The role of a smoke blower at the dispensary, as well as a lack of security footage, put Cookies in the hot spot. Other issues include breaches of state law governing advertising, a document from the state notes.
Earlier this year, Cookies closed a Series A private venture capital fund raise to reach its highest valuation in company history.
HEXO shareholders back Tilray deal
HEXO (NASDAQ:HEXO,TSX:HEXO) had a busy week, with shareholders overwhelmingly supporting the company's plan to be acquired by fellow Canadian producer Tilray (NASDAQ:TLRY,TSX:TLRY).
Approximately 93.7 percent of all votes cast were in favor of the deal, which is expected to close by the end of June. President and CEO Charlie Bowman said HEXO leadership is confident the deal will close in the estimated time.
HEXO also shared its latest quarterly financial results this week, reporting a net loss of C$117.2 million.
On top of the financial the loss, the company reported a net revenue decrease to C$21.6 million, representing an 11 percent drop from the previous quarter.
Cannabis company news
- High Tide (NASDAQ:HITI,TSXV:HITI)issued financial results for its second fiscal quarter of 2023. The firm reported a lower net loss of C$1.6 million, while also celebrating a 46 percent year-on-year revenue uptick to C$118.1 million.
- Canopy Growth (NASDAQ:CGC,TSX:WEED)shared a mandatory operational update. The company is in the process of adjusting its financial results for the fiscal year ended March 31, 2022.
- IM Cannabis (NASDAQ:IMCC,CSE:IMCC)informed shareholders that it has been able to meet the NASDAQ's minimum bid price requirement. "IMC is now in compliance with all applicable listing standards and will continue to be listed and traded on the NASDAQ Stock Market," the company said.
- Verano Holdings (CSE:VRNO,OTCQX:VRNOF)announced that its Alabama subsidiary has earned one of the state's limited integrated facility licenses. “We’ve always had a long-term focus on strengthening our position in the South, and with the addition of Alabama to our footprint, we have an excellent opportunity to increase our presence in an important medical market as cannabis acceptance and state-level programs continue to spread across the growing Southeast region,” George Archos, founder and CEO of the firm, said.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.